Since we found no alterations in uIAPP and total IAPP levels in CSF and plasma and unaltered intensity of the 120kDa IAPP band in CSF of AD patients, we conclude that our studies do not contribute with evidence supporting the use of IAPP as an AD biomarker. This evidence concerns the gene IAPP and Alzheimer disease.